Fig. 3.

Risk of presenting (a) a VL > 50 copies/mL, (b) a %CD4 > 25%, (c) a CD4:CD8 ratio >1, at the latest assessment, according to the period of HIV acquisition: perinatally (P-HIV) or during adulthood (A-HIV), stratified by duration of HIV-1 infection, in univariate and multivariate analyses∗–the French ANRS Coverte, CO10-EPF, Primo Seropri, Copana cohorts. ∗ Adjusted for: gender, country of birth, time-lapse between HIV acquisition and ART initiation, number of previous ART regimens, type of last regimen, and calendar period of last VL measurement).